BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37489991)

  • 41. The Association Between Marital Status, Coronary Computed Tomography Imaging Biomarkers, and Mortality in a Lung Cancer Screening Population.
    Celeng C; Takx RAP; Lessmann N; Maurovich-Horvat P; Leiner T; Išgum I; de Jong PA
    J Thorac Imaging; 2020 May; 35(3):204-209. PubMed ID: 31651690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deep learning model to quantify left atrium volume on routine non-contrast chest CT and predict adverse outcomes.
    Aquino GJ; Chamberlin J; Mercer M; Kocher M; Kabakus I; Akkaya S; Fiegel M; Brady S; Leaphart N; Dippre A; Giovagnoli V; Yacoub B; Jacob A; Gulsun MA; Sahbaee P; Sharma P; Waltz J; Schoepf UJ; Baruah D; Emrich T; Zimmerman S; Field ME; Agha AM; Burt JR
    J Cardiovasc Comput Tomogr; 2022; 16(3):245-253. PubMed ID: 34969636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extending the value of routine lung screening CT with quantitative body composition assessment.
    Xu K; Gao R; Tang Y; Deppen SA; Sandler KL; Kammer MN; Antic SL; Maldonado F; Huo Y; Khan MS; Landman BA
    Proc SPIE Int Soc Opt Eng; 2022; 12032():. PubMed ID: 36303578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.
    Petousis P; Han SX; Aberle D; Bui AA
    Artif Intell Med; 2016 Sep; 72():42-55. PubMed ID: 27664507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting all-cause and lung cancer mortality using emphysema score progression rate between baseline and follow-up chest CT images: A comparison of risk model performances.
    Schreuder A; Jacobs C; Gallardo-Estrella L; Prokop M; Schaefer-Prokop CM; van Ginneken B
    PLoS One; 2019; 14(2):e0212756. PubMed ID: 30789954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Technical Adequacy of Fully Automated Artificial Intelligence Body Composition Tools: Assessment in a Heterogeneous Sample of External CT Examinations.
    Pooler BD; Garrett JW; Southard AM; Summers RM; Pickhardt PJ
    AJR Am J Roentgenol; 2023 Jul; 221(1):124-134. PubMed ID: 37095663
    [No Abstract]   [Full Text] [Related]  

  • 47. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
    Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
    Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
    Landy R; Wang VL; Baldwin DR; Pinsky PF; Cheung LC; Castle PE; Skarzynski M; Robbins HA; Katki HA
    JAMA Netw Open; 2023 Mar; 6(3):e233273. PubMed ID: 36929398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multifactorial Analysis of Mortality in Screening Detected Lung Cancer.
    Digumarthy SR; De Man R; Canellas R; Otrakji A; Wang G; Kalra MK
    J Oncol; 2018; 2018():1296246. PubMed ID: 29861726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening.
    Schreuder A; Jacobs C; Lessmann N; Broeders MJM; Silva M; Išgum I; de Jong PA; Sverzellati N; Prokop M; Pastorino U; Schaefer-Prokop CM; van Ginneken B
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33574075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association of coronary artery calcium score and mortality risk among smokers: The coronary artery calcium consortium.
    Mirbolouk M; Kianoush S; Dardari Z; Miedema MD; Shaw LJ; Rumberger JA; Berman DS; Budoff MJ; Rozanski A; Al-Mallah MH; McEvoy JW; Nasir K; Blaha MJ
    Atherosclerosis; 2020 Feb; 294():33-40. PubMed ID: 31951880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Artificial intelligence to assess body composition on routine abdominal CT scans and predict mortality in pancreatic cancer- A recipe for your local application.
    Hsu TH; Schawkat K; Berkowitz SJ; Wei JL; Makoyeva A; Legare K; DeCicco C; Paez SN; Wu JSH; Szolovits P; Kikinis R; Moser AJ; Goehler A
    Eur J Radiol; 2021 Sep; 142():109834. PubMed ID: 34252866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computed tomography-based body composition measures in COPD and their association with clinical outcomes: A systematic review.
    Nicholson JM; Orsso CE; Nourouzpour S; Elangeswaran B; Chohan K; Orchanian-Cheff A; Fidler L; Mathur S; Rozenberg D
    Chron Respir Dis; 2022; 19():14799731221133387. PubMed ID: 36223552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT.
    Dwivedi K; Sharkey M; Delaney L; Alabed S; Rajaram S; Hill C; Johns C; Rothman A; Mamalakis M; Thompson AAR; Wild J; Condliffe R; Kiely DG; Swift AJ
    Radiology; 2024 Feb; 310(2):e231718. PubMed ID: 38319169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung CAncer SCreening in French women using low-dose CT and Artificial intelligence for DEtection: the CASCADE study protocol.
    Revel MP; Abdoul H; Chassagnon G; Canniff E; Durand-Zaleski I; Wislez M
    BMJ Open; 2022 Dec; 12(12):e067263. PubMed ID: 36600392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
    Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
    Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the epicardial adipose tissue area on non-ECG gated low-dose chest CT useful for predicting coronary atherosclerosis in an asymptomatic population considered for lung cancer screening?
    Lee KC; Yong HS; Lee J; Kang EY; Na JO
    Eur Radiol; 2019 Feb; 29(2):932-940. PubMed ID: 29955949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.